Literature DB >> 22466660

Multiple sclerosis.

Alyssa Nylander1, David A Hafler.   

Abstract

Multiple sclerosis (MS) is a multifocal demyelinating disease with progressive neurodegeneration caused by an autoimmune response to self-antigens in a genetically susceptible individual. While the formation and persistence of meningeal lymphoid follicles suggest persistence of antigens to drive the continuing inflammatory and humoral response, the identity of an antigen or infectious agent leading to the oligoclonal expansion of B and T cells is unknown. In this review we examine new paradigms for understanding the immunopathology of MS, present recent data defining the common genetic variants underlying disease susceptibility, and explore how improved understanding of immune pathway disruption can inform MS prognosis and treatment decisions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466660      PMCID: PMC3314452          DOI: 10.1172/JCI58649

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  116 in total

1.  Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis.

Authors:  Serena Sanna; Maristella Pitzalis; Magdalena Zoledziewska; Ilenia Zara; Carlo Sidore; Raffaele Murru; Michael B Whalen; Fabio Busonero; Andrea Maschio; Gianna Costa; Maria Cristina Melis; Francesca Deidda; Fausto Poddie; Laura Morelli; Gabriele Farina; Yun Li; Mariano Dei; Sandra Lai; Antonella Mulas; Gianmauro Cuccuru; Eleonora Porcu; Liming Liang; Patrizia Zavattari; Loredana Moi; Elisa Deriu; M Francesca Urru; Michele Bajorek; Maria Anna Satta; Eleonora Cocco; Paola Ferrigno; Stefano Sotgiu; Maura Pugliatti; Sebastiano Traccis; Andrea Angius; Maurizio Melis; Giulio Rosati; Gonçalo R Abecasis; Manuela Uda; Maria Giovanna Marrosu; David Schlessinger; Francesco Cucca
Journal:  Nat Genet       Date:  2010-05-09       Impact factor: 38.330

2.  Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.

Authors:  K W Wucherpfennig; I Catz; S Hausmann; J L Strominger; L Steinman; K G Warren
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

Authors:  Eileen J McMahon; Samantha L Bailey; Carol Vanderlugt Castenada; Hanspeter Waldner; Stephen D Miller
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

4.  Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

Authors:  Martin Gunnarsson; Clas Malmeström; Markus Axelsson; Peter Sundström; Charlotte Dahle; Magnus Vrethem; Tomas Olsson; Fredrik Piehl; Niklas Norgren; Lars Rosengren; Anders Svenningsson; Jan Lycke
Journal:  Ann Neurol       Date:  2010-12-08       Impact factor: 10.422

5.  Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.

Authors:  Lars Bö; Jeroen J G Geurts; Paul van der Valk; Chris Polman; Frederik Barkhof
Journal:  Arch Neurol       Date:  2007-01

6.  Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients.

Authors:  M Esposito; V Venkatesh; L Otvos; Z Weng; S Vajda; K Banki; A Perl
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

7.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

8.  Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.

Authors:  Kevin C O'Connor; Katherine A McLaughlin; Philip L De Jager; Tanuja Chitnis; Estelle Bettelli; Chenqi Xu; William H Robinson; Sunil V Cherry; Amit Bar-Or; Brenda Banwell; Hikoaki Fukaura; Toshiyuki Fukazawa; Silvia Tenembaum; Susan J Wong; Norma P Tavakoli; Zhannat Idrissova; Vissia Viglietta; Kevin Rostasy; Daniela Pohl; Russell C Dale; Mark Freedman; Lawrence Steinman; Guy J Buckle; Vijay K Kuchroo; David A Hafler; Kai W Wucherpfennig
Journal:  Nat Med       Date:  2007-01-12       Impact factor: 53.440

9.  Dysregulated T cell expression of TIM3 in multiple sclerosis.

Authors:  Ken Koguchi; David E Anderson; Li Yang; Kevin C O'Connor; Vijay K Kuchroo; David A Hafler
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

10.  Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.

Authors:  K Banki; E Colombo; F Sia; D Halladay; D H Mattson; A H Tatum; P T Massa; P E Phillips; A Perl
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  215 in total

1.  An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.

Authors:  Jonathan J Cho; Joshua M Stewart; Theodore T Drashansky; Maigan A Brusko; Ashley N Zuniga; Kyle J Lorentsen; Benjamin G Keselowsky; Dorina Avram
Journal:  Biomaterials       Date:  2017-07-24       Impact factor: 12.479

2.  Lessons learned at the intersection of immunology and neuroscience.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 3.  Glial regulation of the blood-brain barrier in health and disease.

Authors:  Bieke Broux; Elizabeth Gowing; Alexandre Prat
Journal:  Semin Immunopathol       Date:  2015-08-06       Impact factor: 9.623

Review 4.  Regulation of central nervous system autoimmunity by the aryl hydrocarbon receptor.

Authors:  Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2013-09-03       Impact factor: 9.623

5.  Pericytes modulate myelination in the central nervous system.

Authors:  Patrick O Azevedo; Isadora F G Sena; Julia P Andreotti; Juliana Carvalho-Tavares; José C Alves-Filho; Thiago M Cunha; Fernando Q Cunha; Akiva Mintz; Alexander Birbrair
Journal:  J Cell Physiol       Date:  2018-03-01       Impact factor: 6.384

Review 6.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

Review 7.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

Review 8.  The obesity-related pathology and Th17 cells.

Authors:  Yusuke Endo; Koutaro Yokote; Toshinori Nakayama
Journal:  Cell Mol Life Sci       Date:  2016-10-18       Impact factor: 9.261

9.  Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Authors:  Katarina Tengvall; Jesse Huang; Cecilia Hellström; Patrick Kammer; Martin Biström; Burcu Ayoglu; Izaura Lima Bomfim; Pernilla Stridh; Julia Butt; Nicole Brenner; Angelika Michel; Karin Lundberg; Leonid Padyukov; Ingrid E Lundberg; Elisabet Svenungsson; Ingemar Ernberg; Sigurgeir Olafsson; Alexander T Dilthey; Jan Hillert; Lars Alfredsson; Peter Sundström; Peter Nilsson; Tim Waterboer; Tomas Olsson; Ingrid Kockum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-02       Impact factor: 11.205

Review 10.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.

Authors:  Matthew W Klinker; Cheng-Hong Wei
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.